Patients with genetic cardiomyopathies exhibit a profile of heart-reactive antibodies distinct from the general population
D. Göpfert (Würzburg)
Zum Abstract
(P1323)
Chronic activation of the Anrep effect in regulating myocardial contractility in patients with obstructive hypertrophic cardiomyopathy
K. Peters (Bad Oeynhausen)
Zum Abstract
(P1324)
Real-world efficacy in patients with hypertrophic obstructive cardiomyopathy undergoing myosin inhibitor therapy: Clinical characteristics of incomplete hemodynamic and symptomatic responders
K. Seuthe (Köln)
Zum Abstract
(P1325)
Non-invasive Atrial Cardiomyopathy Diagnosis - How You Measure The P-wave Duration Matters
S. Becker (Bad Krozingen)
Zum Abstract
(P1326)
Identification of Regulatory Elements and Key Genes Associated with Dilated Cardiomyopathy in Left Ventricular Tissue Using Chromatin Interaction and Multi-Omics Integration
A. Muñoz Verdú (Heidelberg)
Zum Abstract
(P1327)
Role of Protein Kinase D1-mediated NLRP3 Activation in Pathogenesis of Sepsis-induced Cardiomyopathy
M. Ghait (Greifswald)
Zum Abstract
(P1328)
Atlas of cardiomyopathy associated DES (desmin) mutations: Focus on the 1B domain